Lidocaine patches are transdermal patches infused with lidocaine which provide local analgesia to neuropathic pain, post-herpetic neuralgia (PHN), and pain associated with diabetic peripheral neuropathy (DPN). These patches are applied to intact skin above the area where patients experience pain. Upon application, lidocaine penetrates the skin and binds to sodium channels, preventing the conduction of nerve impulses associated with pain.

The global lidocaine patches market is estimated to be valued at US$ 6.47 Bn in 2024 and is expected to exhibit a CAGR of 10.% over the forecast period 2024 to 2031, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:
The lidocaine patches market is witnessing high growth owing to rising prevalence of chronic pain disorders across the globe. As per the National Institutes of Health (NIH), chronic pain affects more than 50 million Americans annually. These conditions include arthritis, lower back pain, headache, and neuropathy. According to the Centers for Disease Control and Prevention (CDC), 20.4% of U.S. adults experienced chronic pain in 2019. Lidocaine patches are effective in providing pain relief for these chronic conditions and present a non-invasive alternative to oral pain medications with fewer side effects. Furthermore, growing geriatric population who are more susceptible to chronic pain disorders also presents an opportunity for growth of the lidocaine patches market during the forecast period.

SWOT Analysis
Strength: Lidocaine patches are easy to use and provides localized pain relief for three days with a single application. They help relieve pain quickly and are also non-habit forming alternative to oral pain medications. Medical professionals prefer prescribing lidocaine patches over oral medications due to lower risk of addiction and side-effects.

Weakness: Lidocaine patches have limited applications and can only provide relief for superficial skin pain. They are ineffective for deeper body pain like arthritis. The dosage amount applied through patches cannot be adjusted as per changing pain levels.

Opportunity: With growing geriatric population prone to arthritis and other joint pains, the market for lidocaine patches is expected to grow. Several new products with advanced formulations that can provide pain relief for longer duration are being introduced. Growing awareness about advantages of lidocaine patches over oral medications can boost their demand.

Threats: Stiff competition from generic lidocaine patch manufacturers affects pricing of branded products negatively. Stronghold of older pain therapies also poses challenge to new adoption of lidocaine patches. Non-compliance to application instructions can reduce efficacy of patches.

Key Takeaways
The global lidocaine patches market is expected to witness high growth over the forecast period of 2024 to 2031. Global Lidocaine Patches Market Size is estimated to reach a size of US$ 6.47 billion by 2024 from US$ 4.88 billion in 2021, exhibiting a CAGR of around 10% during the forecast period.

Regional analysis indicates North America dominates the global lidocaine patches market and is expected to maintain its lead throughout the forecast period. Increasing awareness about advantages of lidocaine patches among physicians and patients positively impacts their adoption rate in the region. Major players are focusing on North America region by launching new and enhanced lidocaine patch products.

Key players operating in the lidocaine patches market are Tilray, Canopy Growth Corporation, Aurora Cannabis, Aphria, Cronos Group, Acreage Holdings, MedMen Enterprises, Curaleaf Holdings, Trulieve Cannabis Corporation, Organigram Holdings. These companies collectively account for over 65% of the global market share primarily due to their wide distribution networks and strong brand portfolio of lidocaine patch products.

Get More Insights on this Topic- https://www.dailyprbulletin.com/lidocaine-patches-market-size-outlook-and-forecast/